# The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies

> **NCT06367270** · PHASE2 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 60 (estimated)

## Conditions studied

- Peritoneal Metastases

## Interventions

- **DRUG:** Pressured Intraperitoneal Aerosol Chemotherapy

## Key facts

- **NCT ID:** NCT06367270
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367270, "The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06367270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*